MDxHealth SA (MDXH)
2.86
+0.04
(+1.60%)
USD |
NASDAQ |
May 16, 16:00
2.86
0.00 (0.00%)
After-Hours: 20:00
MDxHealth Debt to Equity Ratio: -37.43 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | -37.43 |
| December 31, 2023 | 5.023 |
| September 30, 2023 | 2.018 |
| June 30, 2023 | 1.344 |
| March 31, 2023 | 0.9464 |
| Date | Value |
|---|---|
| December 31, 2022 | 3.814 |
| September 30, 2022 | 1.642 |
| June 30, 2022 | 0.3713 |
| March 31, 2022 | |
| December 31, 2021 | 0.2578 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-37.43
Minimum
Mar 2024
5.023
Maximum
Dec 2023
-2.446
Average
1.344
Median
Jun 2023
Debt to Equity Ratio Benchmarks
| Galapagos NV | 0.00 |
| UCB SA | 0.3206 |
| Mithra Pharmaceuticals SA | -19.15 |
| Nyxoah SA | 0.0891 |
| Celyad Oncology SA | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 121.74M |
| Total Liabilities (Quarterly) | 122.72M |
| Shareholders Equity (Quarterly) | -0.973M |
| Current Ratio | 1.688 |
| Net Debt Paydown Yield | -0.25% |